Michael Smigelski, MD

Smigelski is a chief resident at NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York.

Articles by Michael Smigelski, MD

Kateryna_Kon - stock.adobe.com

Management of hormone-naïve oligometastatic prostate cancer

ByMichael Smigelski, MD,Rainjade Chung, MD,Christopher B. Anderson MD, MPH

November 23rd 2021

Growing evidence supports the existence of an intermediate metastatic disease state.

Latest Updated Articles

Management of hormone-naïve oligometastatic prostate cancer
November 23rd 2021

Trending on Urology Times

FAQs: The 2026 AUA Guideline on Medical Management of Kidney Stones

Topical sildenafil cream associated with lower systemic exposure vs oral sildenafil

The UroOnc Minute: Neoadjuvant Therapy Before Radical Prostatectomy, With Isaac Y. Kim, MD, PhD, MBA

CHMP recommends perioperative enfortumab vedotin plus pembrolizumab for MIBC

Jonathan Harper, MD, on the importance of fluid intake for reducing stone recurrence